Codes / ICD10CM / F18.11

F18.11 Inhalant abuse, in remission

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Inhalant Abuse, in Remission
  • Medical Term: Inhalant Abuse, in Remission

Summary

Inhalant abuse, in remission, refers to a state where an individual previously met criteria for inhalant abuse but has not engaged in the behavior for a sustained period. This condition indicates a period of abstinence from inhalant misuse, though the risk of recurrence may persist. Remission reflects progress in managing the disorder but does not eliminate the potential for future episodes.

Causes

Inhalant abuse is driven by the repeated misuse of inhalants—substances like glue, paint thinners, or aerosols—for their psychoactive effects. The transition to remission typically involves sustained abstinence, often supported by treatment or personal motivation. However, underlying factors contributing to the original abuse, such as stress or environmental triggers, may still influence the individual.

Risk Factors

  • History of inhalant abuse or dependence.
  • Exposure to inhalant products.
  • Lack of ongoing support or monitoring.
  • Co-occurring mental health conditions.

Symptoms

  • Absence of recent inhalant use.
  • Improved cognitive or physical functioning compared to active abuse.
  • Potential for cravings or urges to use inhalants.
  • Emotional or behavioral changes related to sustained abstinence.

Diagnosis

Clinical evaluation includes a detailed history of inhalant use, assessment of abstinence duration, and review of symptoms. Documentation of sustained remission, typically defined by a specified period without use, is essential. Physical and psychological assessments may be used to confirm stability.

Treatment Options

Treatment focuses on maintaining abstinence and addressing relapse prevention. Options may include counseling, behavioral therapies, or support groups. Ongoing monitoring and follow-up care are often recommended to support long-term recovery.

Prognosis and Follow-Up

Prognosis depends on the individual's commitment to abstinence and access to support. Regular follow-up appointments help track progress, address emerging issues, and adjust treatment as needed. Relapse risk remains, so ongoing vigilance is important.

Complications

  • Risk of relapse to inhalant abuse.
  • Potential for residual physical or cognitive effects from prior use.
  • Emotional challenges related to sustained abstinence.

Lifestyle & Prevention

  • Avoid environments or products associated with inhalant use.
  • Engage in healthy coping mechanisms, such as exercise or mindfulness.
  • Build a strong support network, including family, friends, or support groups.
  • Stay informed about triggers and develop strategies to manage them.

When to Seek Professional Help

Seek help if cravings return, if there is a risk of relapse, or if emotional or behavioral changes indicate potential issues. Professional guidance is also important if new symptoms related to inhalant use emerge.

Tips for Medical Coders

Document the duration of remission and any supporting clinical evidence, such as patient self-report or provider observations. Ensure the code F18.11 is used only when remission criteria are met and clearly documented. Include details about treatment adherence or follow-up care to support the coding decision.

Book a walkthrough

F18.11 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.